Apply by October 27, The Golden Ticket provides a lab bench and office space, and a membership for one year, and access to the AbbVie team of scientific and industry advisors. Application Process. The official application process can be found below. Please read and verify your availability before submitting your application. Complete the application form and upload a non-confidential pitch deck for this competition.
Judging Criteria. Read more about the judging criteria and judges. Scientific experts will review your application and select the most promising ones. A buzzing community. A no strings. Mentoring and support from AbbVie's. Gateway to a. Developing therapeutic platform technologies, including gene therapy, novel drug-discovery or platform technologies. GI - Crohn's, UC. Fibrosis - Sac, IPF. Heme and solid tumors. Novel, differentiated programs - enhance tumor cell targeting, oncogenic signaling pathways, I -O.
Novel approaches to small molecules, including technologies to address hard-to-drug target classes. Alzheimer's and Parkinson's - disease modification. Psychiatric diseases with high unmet need. Next generation solutions for migraine. Spasticity and movement disorders; neurorestoration in multiple sclerosis. Eye Care. Dry eye and ocular surface disease. Glaucoma - intraocular pressure contrit and neuroprotection. Refractive medicine - presbyopia, myopia, corneal dystrophies. Companies must have their principal place of business in the Heidelberg or Paris area or be willing to relocate to one of the locations.
Companies must not have a significant partnership with another large biopharmaceutical company. However, current, or prior recipients of similar awards sponsored by other pharmaceutical companies or lab spaces are eligible to apply. Companies must meet Biolabs' Golden Ticket criteria:. Companies must be in the life sciences and have an impact on human health. The following criteria will form application judging criteria:. Fit relating to the research fields of oncology, immunology, neuroscience, eye care, or aesthetics.
Judges will also consider novel target s identification, drug delivery, discovery technology platforms, and translational research and development. Potential to successfully achieve research milestones and program development. Unmet need for the research in the relevant field.
